Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GARLIC PHYTOCHEMICALS POSSIBLE BENEFIT IN HORMONE-RELATED CANCERS

This article was originally published in The Tan Sheet

Executive Summary

GARLIC PHYTOCHEMICALS POSSIBLE BENEFIT IN HORMONE-RELATED CANCERS suggested in several presentations of preliminary findings of studies discussed at the Designer Foods III conference in Washington, D.C. May 23-25. Researcher John Pinto, PhD, Memorial Sloan-Kettering Cancer Center, asserted that "at several sites ...you see that a number of some of the phytochemicals that exist in food can prevent the [cancer] initiation phase. Many of the compounds in foods certainly act as antioxidants and can block the promotion of tumors and certainly can inhibit a number of hormones that impinge on the growth of hormone-sensitive tissues, particularly breast and prostate."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082844

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel